Ceftin (cefuroxime axetil)
Company: GlaxoWellcome
Approval Status: Approved September 1997
Treatment for: acute bronchitis
Areas: Pulmonary/Respiratory Diseases
General Information
Other Useful Resources
Ceftin (Cefuroxime axetil) has been approved by the U.S. Food and Drug Administration for the treatment of secondary bacterial infections of acute bronchitis with 5-day therapy.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
